DK0876362T3 - Nye taxoider, deres fremstilling og farmaceutiske præparater deraf - Google Patents

Nye taxoider, deres fremstilling og farmaceutiske præparater deraf

Info

Publication number
DK0876362T3
DK0876362T3 DK96942433T DK96942433T DK0876362T3 DK 0876362 T3 DK0876362 T3 DK 0876362T3 DK 96942433 T DK96942433 T DK 96942433T DK 96942433 T DK96942433 T DK 96942433T DK 0876362 T3 DK0876362 T3 DK 0876362T3
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical compositions
new taxoids
taxoids
new
Prior art date
Application number
DK96942433T
Other languages
Danish (da)
English (en)
Inventor
Alain Commercon
Herve Bouchard
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0876362T3 publication Critical patent/DK0876362T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK96942433T 1995-12-22 1996-12-19 Nye taxoider, deres fremstilling og farmaceutiske præparater deraf DK0876362T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1996/002031 WO1997023473A1 (fr) 1995-12-22 1996-12-19 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0876362T3 true DK0876362T3 (da) 2004-02-02

Family

ID=9485871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96942433T DK0876362T3 (da) 1995-12-22 1996-12-19 Nye taxoider, deres fremstilling og farmaceutiske præparater deraf

Country Status (40)

Country Link
US (1) US5728849A (cs)
EP (1) EP0876362B1 (cs)
JP (1) JP3953106B2 (cs)
KR (1) KR100500351B1 (cs)
CN (1) CN1103766C (cs)
AR (1) AR005197A1 (cs)
AT (1) ATE250593T1 (cs)
AU (1) AU712597B2 (cs)
BG (1) BG63204B1 (cs)
BR (1) BR9612135A (cs)
CA (1) CA2238884C (cs)
CO (1) CO4520184A1 (cs)
CZ (1) CZ294972B6 (cs)
DE (1) DE69630145T2 (cs)
DK (1) DK0876362T3 (cs)
DZ (1) DZ2149A1 (cs)
EA (1) EA001533B1 (cs)
ES (1) ES2202490T3 (cs)
FR (1) FR2742751B1 (cs)
HU (1) HU225032B1 (cs)
IL (1) IL124994A (cs)
IN (4) IN186768B (cs)
MA (1) MA26412A1 (cs)
MX (1) MX9804688A (cs)
MY (1) MY113934A (cs)
NO (1) NO317358B1 (cs)
NZ (1) NZ324337A (cs)
OA (1) OA10700A (cs)
PE (1) PE25198A1 (cs)
PL (1) PL189311B1 (cs)
PT (1) PT876362E (cs)
RO (1) RO116194B1 (cs)
SK (1) SK282835B6 (cs)
TN (1) TNSN96169A1 (cs)
TR (1) TR199801179T2 (cs)
TW (1) TW371659B (cs)
UA (1) UA48205C2 (cs)
UY (1) UY24386A1 (cs)
WO (1) WO1997023473A1 (cs)
ZA (1) ZA9610737B (cs)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
WO2001057031A1 (en) 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. C10 carbonate substituted taxanes as antitumor agents
SI1757606T1 (sl) * 2001-02-24 2009-10-31 Boehringer Ingelheim Pharma Ksantinski derivati za uporabo kot zdravila kot tudi postopek za njihovo pripravo
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
CA2526278A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) * 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
CN109503584A (zh) 2006-05-04 2019-03-22 勃林格殷格翰国际有限公司 多晶型
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
ES2733348T3 (es) * 2007-08-17 2019-11-28 Boehringer Ingelheim Int Derivados de purina para uso en el tratamiento de enfermedades relacionadas con FAP
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
MX370599B (es) * 2008-08-15 2019-12-18 Boehringer Ingelheim Int Derivados de purina para su uso en el tratamiento de enfermedades relacionadas con fab.
CN102149407A (zh) 2008-09-10 2011-08-10 贝林格尔.英格海姆国际有限公司 治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
TWI508965B (zh) 2008-12-23 2015-11-21 Boehringer Ingelheim Int 有機化合物的鹽形式
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EP2504002B1 (en) 2009-11-27 2019-10-09 Boehringer Ingelheim International GmbH Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
AU2011249722B2 (en) 2010-05-05 2015-09-17 Boehringer Ingelheim International Gmbh Combination therapy
ES2802243T3 (es) 2010-06-24 2021-01-18 Boehringer Ingelheim Int Terapia para la diabetes
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
KR101985384B1 (ko) 2011-07-15 2019-06-03 베링거 인겔하임 인터내셔날 게엠베하 치환된 퀴나졸린, 이의 제조 및 약제학적 조성물에서의 이의 용도
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
EP4151218A1 (en) 2012-05-14 2023-03-22 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2701076T3 (es) 2012-11-24 2019-02-20 Hangzhou Dac Biotech Co Ltd Enlazadores hidrofílicos y sus usos para la conjugación de fármacos a las moléculas que se unen a las células
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
CA2938919C (en) 2014-02-28 2020-12-29 Hangzhou Dac Biotech Co., Ltd Charged linkers and their uses for conjugation
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
NZ739830A (en) 2015-07-12 2021-12-24 Hangzhou Dac Biotech Co Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合
KR20220147719A (ko) 2016-11-14 2022-11-03 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
WO2022078524A2 (en) 2021-11-03 2022-04-21 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
CA2130578A1 (en) * 1992-04-17 1993-10-28 Geewananda P. Gunawardana Taxol derivatives
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.

Also Published As

Publication number Publication date
CA2238884A1 (fr) 1997-07-03
WO1997023473A1 (fr) 1997-07-03
IN188469B (cs) 2002-09-28
OA10700A (fr) 2002-11-27
EP0876362B1 (fr) 2003-09-24
CN1103766C (zh) 2003-03-26
KR19990076680A (ko) 1999-10-15
HUP9904046A3 (en) 2001-08-28
UA48205C2 (uk) 2002-08-15
DE69630145D1 (de) 2003-10-30
NO317358B1 (no) 2004-10-18
IL124994A0 (en) 1999-01-26
PL327405A1 (en) 1998-12-07
IN188470B (cs) 2002-09-28
IL124994A (en) 2000-12-06
PT876362E (pt) 2004-02-27
EA199800588A1 (ru) 1998-12-24
MY113934A (en) 2002-06-29
IN188680B (cs) 2002-10-26
FR2742751A1 (fr) 1997-06-27
CA2238884C (fr) 2007-02-06
NO982580D0 (no) 1998-06-05
JP3953106B2 (ja) 2007-08-08
AU712597B2 (en) 1999-11-11
PL189311B1 (pl) 2005-07-29
US5728849A (en) 1998-03-17
AR005197A1 (es) 1999-04-14
HU225032B1 (en) 2006-05-29
NZ324337A (en) 2000-03-27
TR199801179T2 (xx) 1998-10-21
CN1205697A (zh) 1999-01-20
FR2742751B1 (fr) 1998-01-30
PE25198A1 (es) 1998-05-10
BG63204B1 (bg) 2001-06-29
BG102569A (en) 1999-04-30
KR100500351B1 (ko) 2005-12-21
TW371659B (en) 1999-10-11
HUP9904046A1 (hu) 2001-04-28
TNSN96169A1 (fr) 2005-03-15
HK1017895A1 (en) 1999-12-03
ZA9610737B (en) 1997-06-27
CZ196198A3 (cs) 1998-09-16
DZ2149A1 (fr) 2002-10-23
EP0876362A1 (fr) 1998-11-11
MX9804688A (es) 1998-10-31
CO4520184A1 (es) 1997-10-15
DE69630145T2 (de) 2004-07-15
CZ294972B6 (cs) 2005-04-13
UY24386A1 (es) 2001-08-27
EA001533B1 (ru) 2001-04-23
RO116194B1 (ro) 2000-11-30
IN186768B (cs) 2001-11-03
NO982580L (no) 1998-06-05
BR9612135A (pt) 1999-07-13
MA26412A1 (fr) 2004-12-20
JP2000502671A (ja) 2000-03-07
ATE250593T1 (de) 2003-10-15
ES2202490T3 (es) 2004-04-01
AU1180997A (en) 1997-07-17
SK282835B6 (sk) 2002-12-03
SK85398A3 (en) 1998-11-04

Similar Documents

Publication Publication Date Title
DK0817779T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
DK0876362T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
DK0820448T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
IS1947B (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
NO996433L (no) Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
DK1263721T3 (da) Farmaceutiske sammensætninger, der indeholder 3-aminoazetidinderivater, nye derivater og fremstilling deraf
FI973039A7 (fi) Uusia farnesyylitransferaasin inhibiittoreita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
FI973279A0 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
NO975710D0 (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
NO961160D0 (no) Cykliske forbindelser, deres fremstilling og anvendelse
IS4706A (is) Lyfjasamsetningar
NO952677D0 (no) Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater
EE9900018A (et) Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid
IS1846B (is) Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur
DE69300913D1 (de) Polymorph Terazosin und pharmazeutische Zusammenstellung.
DK1112266T3 (da) Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
FI972988A0 (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
FI973229A7 (fi) Uusi farmaseuttinen koostumus
NO975365D0 (no) Benzopyraner og farmasöytiske sammensetninger inneholdende dem
NO980471L (no) Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav
NO981195D0 (no) Nye aminoresin sammensetninger
NO974057L (no) Bisykliske takykinin-antagonister, fremstilling derav og deres anvendelse i farmasöytisk sammensetning